Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

President’s Message

Welcome to the April issue of our newsletter which brings news of some important changes as the ALTG continues toPM_Photo evolve. In February the MAC held a face-to-face meeting to discuss plans for the coming three to five years. A major theme of this meeting was how to ensure we maintain the group’s growth and development as the world of lung cancer research becomes increasingly busy and complex.

A key strength of the ALTG is the commitment and dedication of our members, particularly the Management Advisory Committee (MAC) Office Bearers.  At our Members’ Meeting in August we will hold elections for several positions on the MAC, including that of President as I come towards the end of my term. This is an excellent opportunity for those who are interested to become more involved in the group’s overall management. Introducing new Office Bearers to the MAC will also bring a fresh perspective and renewed commitment to the group’s efforts, so I encourage you to consider nominating for these important roles.

The ALTG strategic plan has been reviewed and updated, providing an important framework to guide the group’s activities and ensure we use our limited time and resources to maximum effect. A revised SAC structure has also been developed that offers both greater focus and flexibility for the generation and development of new trial concepts.

In a new article that will feature in each newsletter – Who’s Who – we introduce the members of our Consumer Advisory Panel (CAP). We hope you enjoy learning a little more about this small but important group within the ALTG.

On the Lung Foundation Australia front, at the recent TSANZ meeting, the winners of the Lung Foundation annual Research Awards were announced as well as the establishment of four new awards, of which two are for lung cancer research.

Finally, as we move towards the busier half of the year (if there is such a thing), I look forward to meeting some of you at the ASCO Annual Scientific Meeting, prior to which another important event will take place – the inaugural TACT General Assembly, on June 3.